Theo Pezel, MD, PhD

Cardiologist
Hôpital Lariboisière – APHP, Paris, France
Paris, Ile-de-France, France

MD, PhD, FESC - Researcher in Cardiovascular imaging 🧲 and AI 🤖.
Councillor elected for Cardiac CT and Nuclear Imaging in the EACVI/ESC. Chair of the SIG Committee in EACVI/ESC 🌍
French Group of Young Cardiologists 🇫🇷
#MIRACL.ai #AP-HP
Lariboisiere University Hospital (Paris, France)

Presentation(s):

• Impact of coronary revascularization guided by stress CMR in primary prevention

  Thursday, February 5, 2026
  8:10 AM - 8:20 AM  

• Optimal cut-off point of left ventricular ejection fraction for prediction of death in end‑stage hypertrophic cardiomyopathy with systolic dysfunction

  Thursday, February 5, 2026
  4:40 PM - 4:50 PM  

• Long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance in young patients <45 years

  Friday, February 6, 2026
  10:00 AM - 10:10 AM  

• Prognostic impact of late gadolinium enhancement granularity using cardiovascular magnetic resonance in end‑stage hypertrophic cardiomyopathy

  Friday, February 6, 2026
  10:36 AM - 10:43 AM  

• Hemodynamic forces: a novel non-contrast CMR parameter to detect early cardiac involvement in Sarcoidosis patients

  Saturday, February 7, 2026
  10:15 AM - 10:22 AM  

• (Withdrawn by Presenter) Cardiovascular Magnetic Resonance Late Gadolinium Enhancement Risk Score for Mortality in Patients with Hypertrophic Cardiomyopathy: the HCM-LGE Risk Score

  Saturday, February 7, 2026
  10:50 AM - 10:57 AM